Gapping up
In reaction to strong earnings/guidance: ADBE +5.9%, EMKR +5.7%, ( names Jeffrey Rittichier CEO), HGSH +1.3%
M&A news: TLM +10.6% (attributed to reports suggesting Repsol (REPYY) bid )
Select airline names showing strength: UAL +1.6%, AAL +1.2%, GOL +0.9%, LUV +0.8%
Other news: CCXI +115.1% (announced positive top-line 52-week data from its Phase II clinical trial in diabetic nephropathy with CCX140), WTSL +80.1% (still checking; light volume), FRO +30.7% (cont strength), ONTY +14% (positive ONT-380 Data; Phase 1 data demonstrate preliminary clinical activity; also announced that Array BioPharma (ARRY) has granted Oncothyreon an exclusive license to develop, manufacture and commercialize ONT-380), TLM +10.6% (attributed to reports suggesting Repsol (REPYY) bid ), NBG +5.6% (modest rebound following weakness this week), AHC +4.9% (announced special cash dividend of $2.25 per share), DENN +3.8% (favorable commentary on Thursday's Mad Money), FCEL +3.1% (announces final acceptance of largest fuel cell power plant made and operating in Germany), SSRI +2% (expands mineral resources at marigold with higher gold grade mineralization), NCLH +1.8% (following late move lower on cruiseship fire news), SEAS +1.3% (announced that David D'Allesandro was named interim CEO; also announced a restructuring program across its entire 11-park enterprise), PPHM +1.3% (announces preclinical data from recently conducted single agent studies; statistically significant tumor growth suppression with single agent Bavituximab equivalent), FTR +1.2% (co's Board approved a 5% increase in the quarterly dividend to $0.105 from $0.10 per share), FCE.A +1.1% (Signature Global Asset Management discloses 5.16% passive stake in 13G filing)
Analyst comments: GPRO +4.3% (upgraded to Overweight from Neutral at JP Morgan), DAL +1.4% (target raised to $60 from $48, maintain Buy at Deutsche Bank
)
In reaction to strong earnings/guidance: ADBE +5.9%, EMKR +5.7%, ( names Jeffrey Rittichier CEO), HGSH +1.3%
M&A news: TLM +10.6% (attributed to reports suggesting Repsol (REPYY) bid )
Select airline names showing strength: UAL +1.6%, AAL +1.2%, GOL +0.9%, LUV +0.8%
Other news: CCXI +115.1% (announced positive top-line 52-week data from its Phase II clinical trial in diabetic nephropathy with CCX140), WTSL +80.1% (still checking; light volume), FRO +30.7% (cont strength), ONTY +14% (positive ONT-380 Data; Phase 1 data demonstrate preliminary clinical activity; also announced that Array BioPharma (ARRY) has granted Oncothyreon an exclusive license to develop, manufacture and commercialize ONT-380), TLM +10.6% (attributed to reports suggesting Repsol (REPYY) bid ), NBG +5.6% (modest rebound following weakness this week), AHC +4.9% (announced special cash dividend of $2.25 per share), DENN +3.8% (favorable commentary on Thursday's Mad Money), FCEL +3.1% (announces final acceptance of largest fuel cell power plant made and operating in Germany), SSRI +2% (expands mineral resources at marigold with higher gold grade mineralization), NCLH +1.8% (following late move lower on cruiseship fire news), SEAS +1.3% (announced that David D'Allesandro was named interim CEO; also announced a restructuring program across its entire 11-park enterprise), PPHM +1.3% (announces preclinical data from recently conducted single agent studies; statistically significant tumor growth suppression with single agent Bavituximab equivalent), FTR +1.2% (co's Board approved a 5% increase in the quarterly dividend to $0.105 from $0.10 per share), FCE.A +1.1% (Signature Global Asset Management discloses 5.16% passive stake in 13G filing)
Analyst comments: GPRO +4.3% (upgraded to Overweight from Neutral at JP Morgan), DAL +1.4% (target raised to $60 from $48, maintain Buy at Deutsche Bank
)